Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. News/
      3. Health & wellness/
      4. A 24-hour guide to improving your allergy symptoms
      Health & wellness

      A 24-hour guide to improving your allergy symptoms

      Spring is finally here! And with it comes the start of another allergy season. But with this handy guide, you can help make the transition a bit easier on your body.

      Written by Tamekia Reece
       | March 22, 2017
      March 22, 2017
      A 24-Hour Guide to Improving Your Allergy Symptoms

      Suffering From Seasonal Allergies?

      Find out how to combat symptoms like watery eyes and sneezing this spring.
      Learn more
      Allergy Season: Dandylion lede

      More from Johnson & Johnson

      Latest news
      July 16, 2025

      What you need to know about Johnson & Johnson’s 2025 second-quarter earnings

      Here’s an infographic breakdown of the company’s second-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Read more
      Innovation
      June 25, 2025

      Introducing the first and only daily disposable multifocal contact lens for people with astigmatism

      A Johnson & Johnson scientist explains how the new Acuvue® Oasys Max 1-Day Multifocal for Astigmatism contact lens also filters blue light, supports the eye’s natural tear film and helps eyes easily switch focus from distance to reading.
      Read more
      Health & wellness
      June 12, 2025

      What is wAIHA?

      Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.
      Read more